Bladder Cancer

Clinical research activity is centered on high-risk non-muscle invasive bladder cancer, with interest in disease control after local treatment and prevention of progression in patients with non-muscle invasive disease.

• Non-muscle invasive bladder tumours
• High-risk urothelial cancer
• Progression-free survival

The sponsor’s funded research reflects a focused therapeutic concern in urologic oncology, particularly within bladder-preserving treatment strategies and recurrence prevention.